The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Cost: What You Need to Know BPC 157: Miracle Healing Peptide or Hidden Danger? A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read FDA considers adding a dozen peptides to its bulk drug compounding list RAPS